Unleash the Potential of MedTech With These 3 Stocks

May 24, 2023
By The Investing Insider Staff

Today, we're trading in our battery packs and stethoscopes for a deep exploration of an industry that's drastically changing healthcare as we know it – Medical Technology, or MedTech.

You may ask, "What makes MedTech so captivating?" Strap in, as we're about to delve into this fascinating realm of innovation that's not only altering patient care and enhancing health outcomes but also generating exciting investment possibilities.

At its core, MedTech harnesses technology to enhance healthcare. Envision wearable fitness trackers monitoring your pulse, telemedicine appointments, or advanced robots executing intricate surgeries. With the world becoming progressively digital, MedTech is set for remarkable growth.

In fact, a report by Fortune Business Insights estimates that the global MedTech market could skyrocket to an astounding $718.92 billion by 2029. That's not just a figure; it's an invitation for astute investors like you to act.

But how can you capitalize on this thriving sector? We've got your back. Below is an overview of some top MedTech stocks worth considering:

1) Medtronic (MDT)

Medtronic is a behemoth in the MedTech arena, boasting an extensive range of medical devices and therapies. From cardiac care to diabetes management, they're a MedTech powerhouse. If you're seeking a reliable investment, Medtronic might be the perfect choice.

Factors driving Medtronic's robust performance include its emphasis on innovation, global presence, and solid brand reputation. The company heavily invests in research and development, continually creating new products and therapies tailored to patient needs. Medtronic's strong foothold in emerging markets also fuels growth.

In the most recent quarter, Medtronic reported revenue of $7.7 billion, up 2% QoQ, with an impressive net income of $1.2 billion or $0.92 per share. The company also has a good history of generating strong cash flow; during the latest financial quarter, Medtronic generated $1.4 billion in cash from operations. The company maintains a healthy balance sheet and a manageable debt load.

2) Intuitive Surgical (ISRG)

Familiar with robotic surgery? That's Intuitive Surgical's domain. Their da Vinci surgical system paves the way in robot-assisted surgery. If cutting-edge tech and its potential captivate you, Intuitive Surgical deserves a closer examination.

Intuitive Surgical is a well-managed company with a consistent record of innovation and growth. In the most recent quarter, the company reported revenue of $1.7 billion, up 15% YoY. Net income was $355 million, or $1.00 per share, compared to $324 million, or $0.91 per share, in the previous quarter.

Intuitive Surgical is well-positioned for ongoing growth. The company is benefiting from the rising adoption of robotic surgery, considered a more accurate and minimally invasive alternative to conventional surgery. Intuitive Surgical is also expanding its product portfolio, which should promote future growth.

3) DexCom (DXCM)

DexCom is a significant player in diabetes management, specializing in continuous glucose monitoring (CGM) systems. With diabetes prevalence increasing, DexCom's ground-breaking solutions have never been more pertinent. The company's flagship product, the Dexcom G6, is a real-time CGM system that offers users continuous glucose readings and alerts.

DexCom is a noteworthy player in the CGM arena, widely recognized for its consistent innovation and business growth. In the most recent financial quarter, the company reported a substantial revenue of $742 million, marking a 19% increase from the same period last year. The net income stood at $49 million, equating to earnings of $0.12 per share.

A variety of factors contribute to DexCom's strong performance. Key among these is the growing trend of CGM usage among individuals with diabetes, DexCom's persistent dedication to innovation, and the solid reputation of its brand. With CGM quickly becoming a go-to tool for people with diabetes to efficiently manage their blood sugar levels, DexCom, as an industry pioneer, is relentless in its quest to introduce new features and technology enhancements to its product line.

As always, bear in mind the investor's golden rule: diversification is paramount. While these stocks present promising potential, investing is not without risks. Be sure to do your own research or consult with a financial advisor before making any significant investment decisions.

With the seamless fusion of technology and healthcare, MedTech is leading the charge in a healthcare revolution. For investors eager to embrace the future, this sector is one to monitor. Happy investing, and until next time, stay healthy and wise!

-Investing Insider Staff
This article is informational purposes only and is not investment advice.  See full disclaimer here
Join Investing Insider's "Free Alert Service" today!
Simply fill out the form below get some of our best stock picks deliverd directly to your inbox!

By signing up you agree to our Privacy Policy and Terms.

Featured Articles

About Investing Insider
Investing Insider is a financial education and publishing company. Our team of editors deliver daily tips, picks, and stock market analysis.  Whether you prefer low-risk, deep-value strategies... income investing... or high-risk, high-reward speculative stock picks, we can offer actionable investing ideas to help grow your wealth.
Copyright © 2024 Investing Insider Publishing Ltd. All rights reserved.
30 N Gould St, Suite 2737, Sheridan, WY 82801
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram